Galapagos reported EUR148.04M in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
AstraZeneca AZN:LN USD 10.98B 211M
Biogen BIIB:US USD 2.51B 80.6M
Genmab GEN:DC DKK 4.09B 925M
Gilead Sciences GILD:US USD 7.04B 782M
GlaxoSmithKline GSK:LN GBP 782.9B 90B
Hikma Pharmaceutical HIK:LN USD 1.21B 124M
Merck MRK:GR EUR 5.81B 238M
Neurocrine Biosciences NBIX:US USD 387.9M 9.7M
Novartis NOVN:VX USD 12.84B 243M
Roche Holding ROG:VX CHF 32.3B 207M
Vertex Pharmaceuticals VRTX:US USD 2.33B 138.1M
YTE INCY:US USD 823.3M 88.09M